Poly Medicure Limited - Asset Resilience Ratio
Poly Medicure Limited (POLYMED) has an Asset Resilience Ratio of 18.86% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Poly Medicure Limited to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2026)
This chart shows how Poly Medicure Limited's Asset Resilience Ratio has changed over time. See Poly Medicure Limited balance sheet quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Poly Medicure Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see POLYMED market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs7.39 Billion | 18.86% |
| Total Liquid Assets | Rs7.39 Billion | 18.86% |
Asset Resilience Insights
- Good Liquidity Position: Poly Medicure Limited maintains a healthy 18.86% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Poly Medicure Limited Industry Peers by Asset Resilience Ratio
Compare Poly Medicure Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.87% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Tarsons Products Limited
NSE:TARSONS |
Medical Instruments & Supplies | 0.47% |
|
SciVision Biotech Inc
TW:1786 |
Medical Instruments & Supplies | 7.81% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Annual Asset Resilience Ratio for Poly Medicure Limited (2006–2026)
The table below shows the annual Asset Resilience Ratio data for Poly Medicure Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-03-31 | 18.86% | Rs7.39 Billion ≈ $79.94 Million |
Rs39.19 Billion ≈ $423.78 Million |
-18.70pp |
| 2025-03-31 | 37.57% | Rs11.99 Billion ≈ $129.70 Million |
Rs31.92 Billion ≈ $345.25 Million |
+22.83pp |
| 2024-03-31 | 14.74% | Rs2.74 Billion ≈ $29.62 Million |
Rs18.59 Billion ≈ $201.01 Million |
-15.08pp |
| 2023-03-31 | 29.81% | Rs4.70 Billion ≈ $50.85 Million |
Rs15.77 Billion ≈ $170.57 Million |
+4.84pp |
| 2022-03-31 | 24.98% | Rs3.44 Billion ≈ $37.19 Million |
Rs13.77 Billion ≈ $148.90 Million |
-5.20pp |
| 2021-03-31 | 30.18% | Rs3.69 Billion ≈ $39.94 Million |
Rs12.24 Billion ≈ $132.34 Million |
+25.40pp |
| 2020-03-31 | 4.78% | Rs366.88 Million ≈ $3.97 Million |
Rs7.67 Billion ≈ $82.98 Million |
-2.91pp |
| 2019-03-31 | 7.69% | Rs503.19 Million ≈ $5.44 Million |
Rs6.54 Billion ≈ $70.72 Million |
+2.80pp |
| 2018-03-31 | 4.90% | Rs276.74 Million ≈ $2.99 Million |
Rs5.65 Billion ≈ $61.08 Million |
-0.34pp |
| 2017-03-31 | 5.24% | Rs238.32 Million ≈ $2.58 Million |
Rs4.55 Billion ≈ $49.16 Million |
+3.00pp |
| 2016-03-31 | 2.24% | Rs86.63 Million ≈ $936.85K |
Rs3.87 Billion ≈ $41.84 Million |
+2.25pp |
| 2015-03-31 | -0.01% | Rs-239.00K ≈ $-2.58K |
Rs3.64 Billion ≈ $39.37 Million |
+0.01pp |
| 2014-03-31 | -0.02% | Rs-567.00K ≈ $-6.13K |
Rs2.86 Billion ≈ $30.92 Million |
+0.08pp |
| 2013-03-31 | -0.10% | Rs-2.14 Million ≈ $-23.12K |
Rs2.14 Billion ≈ $23.20 Million |
-0.94pp |
| 2006-03-31 | 0.84% | Rs4.81 Million ≈ $52.02K |
Rs572.69 Million ≈ $6.19 Million |
-- |
About Poly Medicure Limited
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; crit… Read more